These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1800929)

  • 1. Topical cyclosporine in vernal keratoconjunctivitis.
    Bleik JH; Tabbara KF
    Ophthalmology; 1991 Nov; 98(11):1679-84. PubMed ID: 1800929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
    Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitis.
    Akpek EK; Hasiripi H; Christen WG; Kalayci D
    Ophthalmology; 2000 Feb; 107(2):263-9. PubMed ID: 10690822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis.
    Kiliç A; Gürler B
    Can J Ophthalmol; 2006 Dec; 41(6):693-8. PubMed ID: 17224949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical cyclosporine 0.5 per cent and preservative-free ketorolac tromethamine 0.5 per cent in vernal keratoconjunctivitis.
    Kosrirukvongs P; Luengchaichawange C
    J Med Assoc Thai; 2004 Feb; 87(2):190-7. PubMed ID: 15061303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis.
    Pucci N; Novembre E; Cianferoni A; Lombardi E; Bernardini R; Caputo R; Campa L; Vierucci A
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):298-303. PubMed ID: 12269651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
    Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
    Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vernal keratoconjunctivitis in Thailand.
    Kosrirukvongs P; Vichyanond P; Wongsawad W
    Asian Pac J Allergy Immunol; 2003 Mar; 21(1):25-30. PubMed ID: 12931748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose mitomycin-C in severe vernal keratoconjunctivitis: a randomized prospective double blind study.
    Jain AK; Sukhija J
    Indian J Ophthalmol; 2006 Jun; 54(2):111-6. PubMed ID: 16770028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.
    Vichyanond P; Pacharn P; Pleyer U; Leonardi A
    Pediatr Allergy Immunol; 2014 Jun; 25(4):314-22. PubMed ID: 24438133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial.
    De Smedt S; Nkurikiye J; Fonteyne Y; Tuft S; De Bacquer D; Gilbert C; Kestelyn P
    Br J Ophthalmol; 2012 Mar; 96(3):323-8. PubMed ID: 22001151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children.
    Labcharoenwongs P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P; Saengin P; Vichyanond P
    Asian Pac J Allergy Immunol; 2012 Sep; 30(3):177-84. PubMed ID: 23156846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis.
    Sharma A; Gupta R; Ram J; Gupta A
    Indian J Ophthalmol; 1997 Sep; 45(3):177-80. PubMed ID: 9475021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study.
    Leonardi A; Doan S; Amrane M; Ismail D; Montero J; Németh J; Aragona P; Bremond-Gignac D;
    Ophthalmology; 2019 May; 126(5):671-681. PubMed ID: 30593775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis.
    Akpek EK; Dart JK; Watson S; Christen W; Dursun D; Yoo S; O'Brien TP; Schein OD; Gottsch JD
    Ophthalmology; 2004 Mar; 111(3):476-82. PubMed ID: 15019322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twelve-Month Results of Cyclosporine A Cationic Emulsion in a Randomized Study in Patients With Pediatric Vernal Keratoconjunctivitis.
    Bremond-Gignac D; Doan S; Amrane M; Ismail D; Montero J; Németh J; Aragona P; Leonardi A;
    Am J Ophthalmol; 2020 Apr; 212():116-126. PubMed ID: 31770513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical cyclosporin A in the management of vernal keratoconjunctivitis.
    Gupta V; Sahu PK
    Eye (Lond); 2001 Feb; 15(Pt 1):39-41. PubMed ID: 11318292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis.
    Caldwell DR; Verin P; Hartwich-Young R; Meyer SM; Drake MM
    Am J Ophthalmol; 1992 Jun; 113(6):632-7. PubMed ID: 1598953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of Vernal Keratoconjunctivitis and Associated Factors.
    Nebbioso M; Zicari AM; Celani C; Lollobrigida V; Grenga R; Duse M
    Semin Ophthalmol; 2015; 30(5-6):340-4. PubMed ID: 24571721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis.
    Yücel OE; Ulus ND
    Singapore Med J; 2016 Sep; 57(9):507-10. PubMed ID: 26768065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.